The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

OBIO FINANCIAL STATEMENTS

Orchestra BioMed Holdings Inc. — balance sheet, income statement and cash flow trends

OBIOOrchestra BioMed Holdings Inc.

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M0202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue32.7 M $Gross Profit32.5 M $ · 99%Operating Income-55 M $ · -168%Pre-tax Income-54.6 M $ · -167%Net Income to Owners-54.6 M $ · -167%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue32.7 M $+1,033.9%
Gross Profit32.5 M $+1,115.8%
Operating Income-55 M $—
EBITDA-52.7 M $—
Net Income to Owners-54.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
-100 M0100 M200 M202120222023202420252026

Capital Structure

Q1 2026
Total Assets100.7 M
  • Equity51 M $51%
  • Current Liabilities13.7 M $14%
  • Long-term Liabilities36 M $36%

Key Figures

YoY change
Total Assets100.7 M $+70.5%
Total Liabilities49.7 M $+17.8%
Total Equity51 M $+202.3%
Cash & ST Investments94.4 M $+89.2%
Total Debt33.6 M $+104.5%
Net Debt5.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-60 M-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
-50 M0-54.5 M $Operating-29.6 M $Investing94.2 M $Financing10 M $Net Change

Key Figures

YoY change
Operating Cash Flow-54.5 M $—
Capital Expenditures561 K $+42.7%
Free Cash Flow-55.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on OBIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.